[Frontiers in Bioscience 2, d49-60, February 15, 1997]

Table of Conents
 Previous Section   Next Section


Javier Gómez, David García-Domingo, Carlos Martínez-A.1 and Angelita Rebollo

Department of Immunology and Oncology, Centro Nacional de Biotecnología, Campus de Cantoblanco, E-28049 Madrid, Spain

Received 1/21/97; Accepted 1/30/97; On-line 2/15/97


1. R. Sen & D. Baltimore. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-16 (1986).

2. P. A. Baeuerle & T. Henkel. Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 12, 141-79 (1994).

3. U. Siebenlist, G. Franzoso & K. Brown. Structure, regulation and function of NF-kappaB. Annu Rev Cell Biol 10, 405-55 (1994).

4. H. C. Liou & D. Baltimore. Regulation of the NF-kappaB/Rel transcription factor and IkappaB inhibitor system. Curr Opin Cell Biol 5, 477-487 (1993).

5. M. Grilli, J. S. Jason & M. Leonardo. NF-kappaB and related participants in a multiform heterodimer. Cytology 143, 1-62 (1993).

6. A. Israel: A role for phosphorylation and degradation in the control of NF-kappaB activity. Trends Genet 11, 203-5 (1995).

7. A. Beg & A. Baldwin. The IkappaB proteins: multifunctional regulators of Rel/NF-kappaB transcription factors. Genes & Development 7, 2064-70 (1993).

8. T. Gilmore & P. Morin. The IkappaB proteins, members of a multifunctional family. Trends Genet 9, 427-33 (1993).

9. T. Finco & G. Baldwin. Regulation of NF-kappaB: the emerging roles of phosphorylation and proteolysis. Immunity 3, 263-72 (1995).

10. V. Bours, J. Villalobos, P. R. Burd, K. Kelly & U. Siebenlist. Cloning of a mitogen-inducible gene encoding a kappaB DNA-binding protien with homology to the rel oncogene and to cell-cycle motifs. Nature 348, 76-80 (1990).

11. V. Bours, P. R. Burd, K. Brown, J. Villalobos, S. Park, R. P. Ryseck, R. Bravo, K. Kelly & U. Siebenlist. A novel mitogen-inducible gene product related to p50/p105-NF-kappaB participates in transactivation through a kappaB site. Mol Cell Biol 12, 685-95 (1992).

12. T. Henkel, T. Matchleidt, I. Alkalay, M. Kronke, Y. Benneriah & P. A. Baeuerle. Rapid proteolysis of IkappaBalpha is necessary for activation of transcription factor NF-kappaB. Nature 365, 182-85 (1993).

13. F. Mercurio, J. Didonato, C. Rosette & M. Karin. Molecular cloning and characterization of a novel Rel/ NF-kappaB family member displaying structural and functional homology to NF-kappaB p50-p105. DNA Cell Biol 11, 532-37 (1992).

14. V. J. Palombella, O. J. Rando, A. L. Golberg & T. Maniatis. The ubiquitin-proteasome pathway is required for processing the NF-kappaB1 precursor protein and the activation of NF-kappaB. Cell 78, 773-85 (1994).

15. S. Miyamoto & I. M. Verma. NF-kappaB/Rel/IkappaB story. Adv Cancer Res 66, 255-92 (1995).

16. E. B. Kopp & S. Ghosh. NF-kappaB and Rel proteins in innate immunity. Adv Immunol 58, 1-27 (1995).

17. T. Collins, M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos & T. Maniatis. Transcriptional regulation of endothelial cell adhesion molecules NF-kappaB and cytokine-inducible enhancers. FASEB J 9, 899-909 (1995).

18. J. W. Pierce, C. A. Jamieson, J. L. Ross & R. Sen. Activation of IL-2R a chain gene by individual members of the rel oncogene family in association with serum response factor. J Immunol 155, 1972-80 (1995).

19. P. Sperisen, S. M. Wang, E. Soldaini, M. Pla, C. Rusterholz, P. Bucher, P. Corthesy, P. Reichenbach & M. Naboholz. IL-2 and IL-2 control transcription via distinct cis-acting elements. J Biol Chem 270, 10743-53 (1995).

20. W. C. Sha, H. C. Liou, E. I. Tuomanen & D. Baltimore. Targeted disruption of the p50 subunit of NF-kappaB leads to multifocal defects in immature responses. Cell 80, 321-30. (1995).

21. A. A. Beg, W. C. Sha, R. T. Bronson, S. Ghosh & D. Baltimore. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappaB. Nature 376, 167-70 (1995).

22. F. Weih, D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rozzo, R. P. Ryseck, S. A. Lira & R. Bravo. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappaB/Rel family. Cell 80, 331-40 (1995).

23. L. Burkly, C. Hession, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate & D. Lo. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 373, 531-36 (1995).

24. S. Miyamoto, P. J. Chiao & M. Verma. Enhanced IkappaBalpha degradation is responsible for constitutive NF-kappaB activity in mature murine B cell lines. Mol Cell Biol 14, 3276-82 (1994).

25. C. Li, R. M. Dai, E. Chen & D. L. Longo. Phosphorylation of NF-kappaB p50 is involved in NF-kappaB activation and stable DNA binding. J Biol Chem 269, 30089-92 (1994).

26. M. Naumann & C. Scheidereit. Activation of NF-kappaB in vivo is regulated by multiple phosphorylation. EMBO J 13, 4597-07 (1994).

27. A. Ray, M. D. Siegel, K. E. Prefontaine & P. Ray. Anti-inflammation-direct physical association and functional antagonism between transcription factor NF-kappaB and the glucocorticoid receptor. Chest 107, S139-39 (1995).

28. N. R. Rice, M. L. Mackichan & A. Israel. The precursor of NF-kappaB p50 has IkappaB-like functions. Cell 71, 243-53 (1992).

29. E. N. Hatada, M. Naumann & C. Scheidereit. Common structural constituents confer IkappaB activity to NF-kappaB p105 and IkappaB/ MAD-3. EMBO J 12, 2781-88 (1993).

30. J. Inoue, L. D. Kerr, A. Kakizuka & M. Verma. IkappaBgamma, a 70 kD protein identical to the C-terminal half of p110 NF-kappaB. A new member of the IkappaB family. Cell 68, 1109-20 (1992).

31. M. Naumann, F. G. Wulezyn & C. Scheidereit. The NF-kappaB precursor p105 and the proto-oncogene product Bcl-3 are IkappaB molecules and control nuclear translocation of NF-kappaB. EMBO J 12, 213-22 (1993).

32. M. Rechsteiner. PEST sequences are signals for rapid intracellular proteolysis. Sem Cell Biol 1, 433-40 (1990).

33. K. Brown, S. Gerstberger, L. Carlson, G. Franzoso & U. Siebenlist. Control of IkappaBalpha proteolysis by site-specific signal induced phosphorylation. Science 267, 1485-88 (1995).

34. M. S. Rodriguez, I. Michalopoulus, F. Arenzana-Seisdedos & R. T Hay. Inducible degradation of IkappaBalpha in vitro and in vivo requires the acidic C-terminal domain of the protein. Mol Cell Biol 15, 2413-19 (1995).

35. K. H. Mellits, R. T. Hay & S. Goodbourn. Proteolytic degradation of MAD3 and enhanced processing of the NF-kappaB precursor p105 are obligatory steps on the activation of NF-kappaB. Nucleic Acids Res 21, 5059-66 (1993).

36. S. R. Cordle, R. Donald, M. A. Read & J. Hawiger. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappaB proteins in human monocytic HTP-1 cells. J Biol Chem 268, 11803-10 (1993).

37. C. F. Barroga, J. K. Stevenson, E. M. Schwarz & I. M. Verma. Constitutive phosphorylation of IkappaBalpha by casein kinase II. Proc Natl Acad Sci USA 92, 7637-41 (1995).

38. P. J. Chiao, S. Miyamoto & I. M. Verma. Autoregulation of IkappaBalpha activity. Proc Natl Acad Sci USA 91, 22-32 (1994).

39. A. Kumar, J. Haque, J. Lacoste, J. Hiscott & B. Williams. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappaB by phosphorylating IkappaB. Proc Natl Acad Sci USA 91, 6228-32 (1994).

40. S. Lis & J. Sedivy. Raf protein kinase activates the NF-kappaB transcription factor by dissociating the cytoplasmic NF-kappaB-IkappaB complex. Proc Natl Acad Sci USA 90, 9247-51 (1993).

41. T. Finco & A. Baldwin. QkappaB site-dependent induction of gene expression by diverse inducers of NF-kappaB requires Raf-1. J Biol Chem 268, 676-79 (1993).

42. E. M. Genot, P. J. Parker & D. A. Cantrell. Analysis of the role of PKC alpha, epsilon and zeta in T cell activation. J Biol Chem 270, 9833-38 (1995).

43. M. T. Diaz-Meco, I. Dominguez, I. Sanz, P. Dent, J. Lozano, M. Municio, E. Berra, R. Hay, T. Sturgill & J. Moscat. PKC zeta induces phosphorylation and inactivation of IkappaBalpha in vitro. EMBO J 13, 2842-48 (1994).

44. H. M. Lander, J. S. Ogiste, S. F. Pearce, R. Levi and A. Novogrodsky. Nitric oxid stimulated guanine nucleotide exchange on p21ras. J Biol Chem 270, 7071-77 (1995).

45. R. I. Scheinman, P. G. Cogswell, A. K. Lofquist & A. S. Baldwin. Role of transcriptional activation of IkappaBalpha in mediation of immunosuppression by glucocorticoids. Science 270, 283-86 (1995).

46. B. Frantz, E. Nordby, G. Bren, N. Stefan, C. Pava, R. Kinkaid & E. O'Neill. Calcineurin acts in synergy with PMA to inactivate IkappaB/MAD3, an inhibitor of NF-kappaB. EMBO J 13, 861-70 (1994).

47. S. M. Kang, A. C. Tran, M. Grilli & M. J. Lenardo. NF-kappaB subunit regulation in nontransformed CD4+ T lymphocytes. Science 256, 1452-56 (1992).

48. J. A. Lederer, J. S. Liou, M. D. Todd, L. H. Glincher & A. H. Lichtman. Regulation of cytokine gene expression in T-helper subsets. J Immunol 152, 77-86 (1994).

49. N. Davis, S. Ghosh, D. L. Simmons, P. Tempst, H. C. Liou, D. Baltimore & H. R. Bose. Rel-associated pp40: An inhibitor of the Rel family of transcription factors. Science 253, 1268-71 (1991).

50. X. Xu, C. Prorock, H. Ishikawa & E. Maldonado. Functional interaction of the v-Rel and c-Rel oncoprotein with the TATA-binding protein and association with transcription factor IIB. Mol Cell Biol 13, 6733-41 (1993).

51. L. D. Kerr, L. J. Ransone, P. Wamsley, M. J. Schmitt, T. G. Boyer, Q. Zhou, A. J. Berk & I. M. Verma. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappaB. Nature 365, 412-19 (1993).

52. D. Thanos & T. Maniatis: The high mobility group protein HMG-I(Y) is required for NF-kappaB-dependent virus induction of the human IFN-ß gene. Cell 71, 777-89 (1992).

53. D. Tahanos & T. Maniatis. NF-kappaB: A lesson in family values. Cell 80, 529-32 (1995).

54. H. M. Wang & K. A. Smith. The IL-2 receptor: functional consequences of its biomolecular structure. J Exp Med 166, 1055-1063 (1987).

55. T. Takeshita, H. Asao, K. Othani, N. Ishi, S. Kumaki, N. Tanaka, H. Munakata, M. Takamura & K. Sugamura. Cloning of the gamma chain of the IL-2 receptor. Science 257, 379-382 (1992).

56. M. Hatakeyama, M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, M. Miyasaka & T. Taniguchi. IL-2 beta gene: generation of three receptor forms by cloned human alpha and beta chains. Science 244, 551-554 (1989).

57. W. C. Greene & W. J. Leonard. The IL-2 receptor system. Annu Rev Immunol 4, 69-80 (1986).

58. B. B. Lin, S. L. Cross, N. F. Halden, D. G. Roman, M.B. Toledano & W. J. Leonard. Delineation of an enhancer like positive regulatory element in the IL-2Ra chain gene. Mol Cell Biol 10, 850-53 (1990).

59. D. W. Ballard, E. Bohnlein, J. W. Lowenthal, Y. Wano, B.R. Franza & W.C. Greene. HTLV-1 Tax induces cellular proteins that activate the kappaB element in the IL-2Ra gene. Science 241, 1652-59 (1988).

60. K. Leung & G. Nabel. HTLV-1 transactivator induces IL-2R expression through an NF-kappaB like factor. Nature 333, 776-81 (1988).

61. J. L. Pomerantz, F. Mauxion, M. Yoshida, W.C. Greene & R. Sen. A second sequence element located 3' to the NF-kappaB binding site regulates IL-2Ra gene induction. J Immunol 143, 4275-81 (1989).

62. M. B. Toledano, D. G. Roman, N.F. Halden, B. B. Lin & W. J. Leonard. The same target sequences are differentially important for activation of the IL-2Ralpha gene in two distinct T cell lines. Proc Natl Acad Sci USA 87, 1830-36 (1990).

63. D. W. Ballard, E. Bohnlein, J. A. Hoffman, H.P. Bogerd, E. P. Dixon, B.R. Franza & W. C. Greene. Activation of the IL-2Ralpha gene: regulatory role for DNA-protein interactions flanking the kappaB enhancer. New Biol 1, 83-92 (1989).

64. E. Bohnlein, J. W. Lownthal, M. Siekevitz, D. W. Ballard, B. R. Franza & W. C. Greene. The same inducible nuclear proteins regulate mitogen activation of both IL-2Ralpha gene and type I HIV. Cell 53, 827-36 (1988).

65. S. L. Cross, N. F. Halden, M. J. Lenardo & W. J. Leonard. Functional distinct NF-kappaB binding sites in the Ig k and IL-2Ralpha chain genes. Science 244, 466-69 (1989).

66. J. W. Lownthal, D. J. Ballard, E. Bohnlein & W. C. Greene. Tumor necrosis factor a induces proteins that bind specifically to kappaB like enhancer elements and regulate IL-2RQalpha gene expression in primary human T lymphocytes. Proc Natl Acad Sci USA 86, 2331-35 (1989).

67. E. Soldaini, M. Pla, F. Bermann, E. Espel, P. Corthesi, S. Borange, G. A. Waanders, H. R. McDonald & M. Nabohlz. Mouse IL-2Ralpha gene expression: delimitation of cis-acting regulatory elements in transgenic mice and by mapping of DNAse hypersensitive sites. J Biol Chem 270, 10733-42 (1995).

68. C. B. Thompson, C. Y. Wang, C. Ho, P. R. Bohjanene, B. Petryniak, C. H. June, S. Miesfeldt, L. Zang, G. J. Nabel, B. Karpinski & J. M. Leiden. cis-acting sequences required for inducible IL-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol 12, 1043-53 (1992).

69. T. S. Elton & R. Reeves. Purification and post-synthetic modifications of Friend erythroleukemic cell high mobility group protein HGM-1. Anal Biochem 157, 53-62 (1986).

70. K. R. Johnson, D. A. Lehn & R. Reeves. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I amd HMG-Y. Mol Cell Biol 9, 2114-23 (1989).

71. T. Lund, J. Holtlund, M. Fredricksen & S. G. Laland. On the presence of two new high mobility group-proteins in HeLaS3 cells. FEBS Lett 152, 163-7 (1983).

72. T. H. Tan, G. P. Huang, A. Sica, P. Ghosh, H. A. Young, D. L. Longo & N. C. Rice. kappaB site-dependent activation of the IL-2alpha chain gene promoter by human c-Rel. Mol Cell Biol 12, 4067-75 (1992).

73. J. M. Leiden, C. Y. Wang, D. M. Petryniak, D. M. Markovitz, G. J. Nabel and C. B. Thompson. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans-activation in T cells. J Virol 66, 5890-97 (1992).

74. S. John, R. B. Reeves, J. Lin, R. Child, J. M. Leiden, C. B. Thompson & W. J. Leonard. Regulation of cell type-specific IL-2Ralpha chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y) and NF-QkappaB family proteins. Mol Cell Biol 15, 1786-96 (1995).

75. W. Du, D. Thanos & T. Maniatis. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74, 887-98 (1993).

76. J. W. Pierce, C. A. Jamieson, J. L. Ross & R. Sen. Activation ol IL-2Ra chain gene by individual members of the Rel oncogene family in association with serum response factor. J Immunol 155, 1972-80 (1995).

77. L. D. Kerr, L. J. Ransone, P. Wamsley, M. J. Schmitt, T. G. Boyer, Q. Zhou, A. Berk & I. M. Verma. Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappaB. Nature 365, 412-29 (1993).

78. M. Pearse, I. Wu, M. Egerton, A. Wilson, K. Shortman & R. Scollay. A murine early thymocyte developmental sequence is marked by transient expression of the IL-2R. Proc Natl Acad Sci USA 86, 1614-19 (1989).

79. A. A. Kuang, K. D. Novak, S. Kang, K. Bruhn & M. J. Lenardo. Interaction between NF-kappaB and serum response factor-binding elements activates an IL-2Ralpha chain enhancer specifically in T lymphocytes. Mol Cell Biol 13, 2536-41 (1993).

80. J. Sen, L. Venkatarmanan, Y. Shinkai, J. W. Pierce, F. W. Alt, S. J. Burakoff & R. Sen. Expression and induction of NF-kappaB related proteins in thymocytes. J Immunol 154, 3213-18 (1995).

81. V. Ivanov & R. Ceredig. Transcription factors in mouse fetal thymus development. Int Immunol 4, 729-35 (1992).

82. C. Abbadie, N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Bandenbunder & P. J. Enrietto. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75, 899-912 (1993).

83. P. A. Baeuerle & D. Baltimore. NF-kappaB: ten years after. Cell 87, 13-20 (1996).

84. M. Jung, Y. Zhang, S. Lee & A. Dritschilo. Correction of radiation sensitivity in ataxia telangiectasia by a truncated IkappaB-alpha. Science 268, 1619-21 (1995).

85. D. W. White, A. Roy & T. D. Gilmore. The v-Rel oncoprotein blocks apoptosis and proteolysis of IkappaB-alpha in transformed chicken spleen cells. Oncogene 10, 857-68 (1995).

86. A. A. Beg & D. Baltimore. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274, 782-4 (1996).

87. C.-Y. Wang, M. W. Mayo & A. S. Baldwin Jr. TNF-alpha and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274, 784-787 (1996).

88. D. J. Van Antwerp, S. J. Martin, T. Kafri, D. R. Green & I. M. Verma. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789 (1996).

89. S. Grimm, M. K. Bauer, P. A. Baeuerle & K. Schulze-Osthoff. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol 134, 13-23 (1996).

90. M. Wu, L. Hayyoung, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. FitzGerald, T. L. Rothstein, D. H. Sherr & G. E. Sonenshein. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 15, 4682-90 (1996).

91. A. H. Wyllie. The genetic regulation of apoptosis. Curr Opin Genet Dev 5, 97-104 (1995).

92. W. Meikrantz & R. Schlegel. Apoptosis and the cell cycle. J Cell Biochem 58, 160-74 (1995).

93. G. I. Evan, L. Brown, M. Whyte & E. Harrington. Apoptosis and the cell cycle. Curr Opin Cell Biol 7, 825-34 (1995).

94. V. Chiarugi, L. Magnelli, M. Cinelli & G. Basi. Apoptosis and the cell cycle. Cell Mol Biol Res 40, 603-612 (1994).

95. E. A. Harrington, A. Fanidi & G. I. Evan. Oncogenes and cell death. Curr Opin Genet Dev 4, 120-9 (1994).

96. J. Gómez, A. García, L. Borlado, P. Bonay, C. Martínez-A., M. Fresno, A. Carrera, A. Silva & A. Rebollo. IL-2 signaling controls actin organization through Rho-like protein family, PI3 kinase and PKC zeta. J Immunol 157, in press (1997).

97. F. McCormick. Ras-related proteins in signal transduction and growth control. Mol Reprod Dev 42, 500-6 (1995).

98. I. G. Macara, K. M. Lounsbury, S. A. Richards, C. McKiernan & D. Bar Sagi. The Ras superfamily of GTPases. FASEB J 10, 625-30 (1996).

99. C. J. Marshall. Ras effectors. Curr Opin Cell Biol 8, 197-204 (1996).

100. J. Gómez, C. Martínez-A. & A. Rebollo. Ras-mediated cell proliferation and cell death: some clues from the interleukin 2 receptor system. Apoptosis, in press (1997).

101. P. Esteve, L. del Peso & J. C. Lacal. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis. Oncogene 11, 2657-65 (1995).

102. B. Jimenez, M. Arends, P. Esteve, R. Perona, R. Sanchez, S. Ramon y Cajal, A. Wyllie & J. C. Lacal. Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily. Oncogene 10, 811-6 (1995).

103. J. Gómez, C. Martínez-A., B. Fernández, A. García & A. Rebollo. Critical role of Ras in the proliferation and prevention of apoptosis mediated by IL-2. J Immunol 157, 2272-81 (1996).

104. J. Alcami, T. Delera, L. Folgueria, M. Pedraza, J. Jacque, F. Bachelerie, A. Noriega, R. Hay, D. Harrich, R. Gaynor, J. Virelizier & F. Arenzana-Seisdedos. Absolute dependence on kappaB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 14, 1552-60 (1995).

105. R. Schreck, P. Rieber & P. A. Baeuerle. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappaB transcription factor and HIV-1. EMBO J 10, 2247-58 (1991).

106. H. Satake, K. Suzuki, T. Aoki, M. Otsuka, Y. Sugiura, T. Yamamoto & J. Inoue. Cupric ion blocks NF-kappaB activation through inhibiting the signal-induced phosphorylation of IkappaBalpha. Biochem Biophys Res Comm 216, 568-73 (1995).

107. T. Miyazaki, Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Perlmutter & T. Taniguchi. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc and lck cooperate in hematopoietic cell proliferation. Cell 81, 223-31 (1995).

108. A. Rebollo, J. Gómez & C. Martínez-A. Lessons from immunological, biochemical, and molecular pathways of the activation mediated by IL-2 and IL-4. Adv Immunol 63, 127-96 (1996).

109. A. Rebollo, I. Merida, J. Gómez, C. Pitton, A. Silva, C. Martínez-A. & A. García. Differential effect of rapamycin and cyclosporin A in proliferation in a murine T cell line expressing either intermediate or high affinity receptor for IL-2. Cytokine 7, 277-85 (1995).

110. S. Ferrari, R. B. Pearson, M. Siegmann, S. C. Kozma & G. Thomas. The immunosuppressant rapamycin induces inactivation of p70s6k through dephosphorylation of a novel set of sites. J Biol Chem 268, 16091-4 (1993).

111. J. W. Han, R. B. Pearson, P. B. Dennis & G. Thomas. Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites. J Biol Chem 270, 21396-403 (1995).

112. R. B. Pearson, P. B. Dennis, J. W. Han, N. A. Williamson, S. C. Kozma, R. E. Wettenhall & G. Thomas. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J 14, 5279-87 (1995).

113. J. Kunz, R. Henriquez, U. Schneider, M. Deuter-Reinhard, N. R. Movva & M. N. Hall. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585-96 (1993).

114. D. M. Sabatini, B. A. Pierchala, R. K. Barrow, M. J. Schell & S. H. Snyder. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity. J Biol Chem 270, 20875-8 (1995).

115. M. W. Albers, R. T. Williams, E. J. Brown, A. Tanaka, F. L. Hall & S. L. Schreiber. FKBP-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J Biol Chem 268, 22825-9 (1993).

116. M. Hirano, S. Hirai, K. Mizuno, S. Osada, M. Hosaka & S Ohno. MEK kinase is involved in TNF-alpha induced NF-kappaB activation and IkappaBalpha degradation. Biochem Biophys Res Comm 206, 429-33 (1995).